Literature DB >> 1488068

Loss and renewal of thick myofilaments in glucocorticoid-treated rat soleus after denervation and reinnervation.

R Massa1, S Carpenter, P Holland, G Karpati.   

Abstract

Denervation of rat soleus muscle and simultaneous administration of high doses of corticosteroids for 7 days caused marked muscle fiber atrophy and selective loss of thick myofilaments from many muscle fibers by light and electron microscopy. Myosin heavy chain/actin ratios were greatly reduced on polyacrylamide gel electrophoresis. Nerve crush instead of cut permitted reinnervation after 2 weeks and demonstrated the reversibility of the muscle changes within a week after reinnervation. There was formation of new thick filaments and their reintegration into myofibrils without further breakdown, although large areas of Z-disc streaming appeared. The mechanism of A-band breakdown remains obscure, but it presumably starts with limited proteolysis and continues with disaggregation of myosin molecules. This is consistent with our observation that the muscle fibers retain a relatively good reactivity to antibodies against myosin heavy chain 1 week after denervation and corticosteroid administration. A syndrome recalling these experiments is seen in severely asthmatic patients receiving corticosteroids and pharmacologically paralyzed for mechanical respiration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1488068     DOI: 10.1002/mus.880151112

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

Review 1.  [Intensive care unit-acquired weakness in the critically ill : critical illness polyneuropathy and critical illness myopathy].

Authors:  K Judemann; D Lunz; Y A Zausig; B M Graf; W Zink
Journal:  Anaesthesist       Date:  2011-10       Impact factor: 1.041

Review 2.  Dysregulation of sodium channel gating in critical illness myopathy.

Authors:  James W Teener; Mark M Rich
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

3.  Distinct muscle apoptotic pathways are activated in muscles with different fiber types in a rat model of critical illness myopathy.

Authors:  Benjamin T Barnes; Amy L Confides; Mark M Rich; Esther E Dupont-Versteegden
Journal:  J Muscle Res Cell Motil       Date:  2015-03-05       Impact factor: 2.698

Review 4.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

5.  Upregulation of the CaV 1.1-ryanodine receptor complex in a rat model of critical illness myopathy.

Authors:  Susan D Kraner; Qingbo Wang; Kevin R Novak; Dongmei Cheng; David R Cool; Junmin Peng; Mark M Rich
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-04-06       Impact factor: 3.619

Review 6.  Critical illness myopathy and polyneuropathy.

Authors:  Shawn J Bird; Mark M Rich
Journal:  Curr Neurol Neurosci Rep       Date:  2002-11       Impact factor: 5.081

7.  Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS.

Authors:  Catherine L Hough; Kenneth P Steinberg; B Taylor Thompson; Gordon D Rubenfeld; Leonard D Hudson
Journal:  Intensive Care Med       Date:  2008-10-23       Impact factor: 17.440

Review 8.  Mechanisms of neuromuscular dysfunction in critical illness.

Authors:  Jaffar Khan; Taylor B Harrison; Mark M Rich
Journal:  Crit Care Clin       Date:  2008-01       Impact factor: 3.598

Review 9.  Critical illness myopathy.

Authors:  David Lacomis
Journal:  Curr Rheumatol Rep       Date:  2002-10       Impact factor: 4.592

Review 10.  Clinical review: Critical illness polyneuropathy and myopathy.

Authors:  Greet Hermans; Bernard De Jonghe; Frans Bruyninckx; Greet Van den Berghe
Journal:  Crit Care       Date:  2008-11-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.